All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 10 out of 26 Insights
-
Active Filters
-
Can Addressing One Disease Transform Global Health?
HealthSpark, Episode 25: Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School, reflects on why obesity is one of modern medicine's most complex challenges and how coordinated action across care delivery, public health, and industry can reduce its impact on patients, health systems, and economies worldwide.
-
How Long Can Health Systems Afford to Sideline the Private Sector?
HealthSpark, Episode 24: Tisha Boatman, Executive Vice President of External Affairs at Siemens Healthineers, reflects on how changing funding dynamics, shifting attitudes toward collaboration, and a more ecosystem‑oriented mindset are redefining the role of the private sector in health systems worldwide.
-
When Patients are Hungry, Uninsured, and Scared, What Does High-Quality Care Look Like?
HealthSpark, Episode 23: Mallika Marshall, an internal medicine physician at Massachusetts General Hospital’s Chelsea Urgent Care Clinic and Revere Health Center, explores what it takes to deliver equitable, patient-centered care in the face of profound social and economic barriers.
-
Why are Millions Dying from a Curable Disease?
HealthSpark, Episode 22: Rushdy Ahmad, Director of the Diagnostics Accelerator at Harvard's Wyss Institute, examines why curable diseases like tuberculosis still claim so many lives. He discusses what it will take across science, funding, and policy to get simple tests into the places where people need them most.
-
Are Hospitals Trying to do too Much for too Many Patients?
HealthSpark, Episode 21: Mary Witkowski, Fellow at Harvard Business School's Institute for Strategy & Competitiveness and a member of the teaching faculty at Harvard Medical School, examines how shifting from "do everything" hospitals to condition‑focused care teams can improve outcomes, reduce waste, and create a better experience for both patients and clinicians.
-
How Do We Match the Right Drug to the Right Patient?
HealthSpark, Episode 20: Tanya M. Laidlaw, MD, Professor of Medicine at Harvard Medical School and allergist-immunologist at Brigham and Women’s Hospital, shows how treating severe asthma with advanced biologics can still feel like trial-and-error, and why linking patient experience, biomarkers, and research is critical to getting treatment right the first time.
-
Are Legacy Systems Holding Back Digital Health Innovation?
HealthSpark, Episode 19: Ariel Stern, Alexander von Humboldt Professor for Digital Health, Economics, and Policy at the Hasso Plattner Institute and Professor at the University of Potsdam, discusses why so many promising digital health tools fail to move beyond pilot projects and outlines the steps health systems, payers, and industry partners must take to integrate these solutions into routine care for patients and clinicians.
-
Is Obesity Our Most Visible and Misunderstood Health Inequity?
HealthSpark, Episode 18: Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School, explains why obesity is one of the most complex challenges in modern health care and explores what it will take to replace blame with evidence‑based, compassionate action.
-
What Happens When Your Watch Starts Acting Like a Clinician?
HealthSpark, Episode 17: Elliott Antman, Cardiologist and Senior Physician at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School, examines how smartwatches and other consumer devices are redefining what patients notice and bring into the exam room, and how clinicians can use this data effectively.
-
Is Private Equity Strengthening Health Care, or Eroding it from Within?
HealthSpark, Episode 16: Leemore Dafny, an applied microeconomist and former Deputy Director for Health Care and Antitrust at the Federal Trade Commission, examines how private equity-driven consolidation is reshaping health care spending and market stability, and whether these deals serve the public interest by protecting access, affordability, quality, and competition.
